Lineage Cell Therapeutics
LCTX
#8012
Rank
โ‚ฌ0.27 B
Marketcap
1,12ย โ‚ฌ
Share price
-1.52%
Change (1 day)
82.00%
Change (1 year)

Earnings for Lineage Cell Therapeutics (LCTX)

Earnings in 2025 (TTM): -โ‚ฌ18.35 Million

According to Lineage Cell Therapeutics 's latest financial reports the company's current earnings are โ‚ฌ10.81 Million. In 2024 the company made an earning of -โ‚ฌ18.51 Million, an increase over its 2023 earnings that were of -โ‚ฌ21.32 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lineage Cell Therapeutics from 1992 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ18.35 Million-0.9%
2024 -โ‚ฌ18.51 Million-13.16%
2023 -โ‚ฌ21.32 Million9.83%
2022 -โ‚ฌ19.41 Million-54.24%
2021 -โ‚ฌ42.41 Million86.07%
2020 -โ‚ฌ22.79 Million-31.97%
2019 -โ‚ฌ33.5 Million-5.42%
2018 -โ‚ฌ35.42 Million1.1%
2017 -โ‚ฌ35.04 Million-31.06%
2016 -โ‚ฌ50.82 Million-10.38%
2015 -โ‚ฌ56.71 Million29.69%
2014 -โ‚ฌ43.73 Million31.68%
2013 -โ‚ฌ33.21 Million
2011 -โ‚ฌ16.12 Million89.78%
2010 -โ‚ฌ8.5 Million206.06%
2009 -โ‚ฌ2.78 Million-0.58%
2008 -โ‚ฌ2.8 Million164.89%
2007 -โ‚ฌ1.06 Million-30.22%
2006 -โ‚ฌ1.51 Million
2002 -โ‚ฌ1.76 Million-41.04%
2001 -โ‚ฌ2.98 Million-32.04%
2000 -โ‚ฌ4.38 Million-11.85%
1999 -โ‚ฌ4.97 Million
1997 -โ‚ฌ3.19 Million12.12%
1996 -โ‚ฌ2.85 Million106.25%
1995 -โ‚ฌ1.38 Million-11.11%
1994 -โ‚ฌ1.56 Million50%
1993 -โ‚ฌ1.04 Million20%
1992 -โ‚ฌ0.87 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-โ‚ฌ0.13 Billion 603.03%๐Ÿ‡บ๐Ÿ‡ธ USA